{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-058049","form_type":"8-K","ticker":"ALBT","cik":"0001630212","company_name":"Avalon GloboCare Corp.","filed_at":"2025-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.127320+00:00","generated_at":"2026-05-18T17:54:58.244194+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Avalon GloboCare and Qi Diagnostics agree to co-develop cannabis breathalyzer for impaired driving detection","bullets":["Definitive agreement for co-development of VOC nanosensor-based point-of-care cannabis breathalyzer.","Total milestone payments up to $975,000 across four stages: data collection, prototype design, production, human testing.","Qi Diagnostics retains IP; Q&A (Avalon sub) earns up to 50% passive financial interest in IP upon all milestones.","Device aims to support real-time detection of cannabis-impaired driving for law enforcement and workplace safety."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-058049","json":"https://secwatch.observer/filing/0001213900-25-058049.json","markdown":"https://secwatch.observer/filing/0001213900-25-058049.md","text":"https://secwatch.observer/filing/0001213900-25-058049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025058049/0001213900-25-058049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025058049/ea0246882-8k_avalon.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T17:54:58.244194+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}